Analytical Data
-
基因名
FKBP9L
- Application
-
别名
FKBP9P1; FKBP9LPutative FK506-binding protein 9-like protein; FK506-binding protein 9-like protein pseudogene
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q75LS8
-
表达区间
1-142aa
-
氨基酸序列
MDMGLREMCVGEKRTVIIPPHLGYGEAGVDGEVPGSAVLVFDIELLELVAGLPEGYMFIWNGEVSPNLFEEIDKDGNGEVLLEEFSEYIHAQVASGKGKLAPGFDAELIVKNMFTNQDRNGDGKVTAEEFKLKDQEAKQDEL
-
分子量
42 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human CCDC80 Protein，His
Cat：PA1000-8563
Recombinant Human FKBP11 Protein，GST
Cat：PA2000-7671
Protein Description
FKBP9L, or FK506-binding protein 9-like, is a member of the FKBP family of immunophilins known for their role in protein-folding and modulation of various cellular processes. Research into FKBP9L has gained interest due to its potential involvement in critical physiological functions, including regulating immune responses and cellular stress responses. It has been implicated in various diseases, such as cancer, neurodegenerative disorders, and autoimmune conditions, making it a candidate for therapeutic targeting. The protein exhibits peptidyl-prolyl isomerase activity, which can influence protein conformation and function, suggesting its role in signal transduction pathways. Moreover, FKBP9L interacts with multiple cellular partners, including heat shock proteins and transcription factors, further underscoring its significance in maintaining cellular homeostasis. Understanding the structure and function of FKBP9L through recombinant protein studies can provide insights into its biological roles and potential as a drug target, paving the way for novel therapeutic approaches in treating various diseases linked to its dysregulation.
